Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Consumer Staples Select Sector SPDR Fund — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B), while Consumer Staples Select Sector SPDR Fund trades at $87.43 (market cap $14.73B). The key difference: Consumer Staples Select Sector SPDR Fund is far larger — about 2.9× Oruka Therapeutics Inc. Common Stock's market cap, and Consumer Staples Select Sector SPDR Fund is trading nearer its 52-week high, Oruka Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Consumer Staples Select Sector SPDR Fund for 73 Days on average.
| ORKA | XLP | |
|---|---|---|
Market Cap | $5.08B | $14.73B |
Volume | 685,276 | 14,288,954 |
Sector | Health | — |
52-Week High | $113.08 | $90.00 |
52-Week Low | $26.19 | $75.61 |
Typical Hold Time | 0 Days | 73 Days |
Enterprise Value | $4.21B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLP trades at $84.19, down 0.26% on the day, with strong technical momentum showing a bullish moving average signal despite an overbought RSI reading. The ETF maintains 100% analyst buy ratings and recently announced a $0.54 dividend payable in September 2026. Consumer staples sector performance has been resilient, with XLP gaining 6.6% year-to-date while outperforming discretionary counterparts by over 13 percentage points.
The defensive nature of consumer staples provides stability amid market volatility, though elevated interest rates pose a headwind. With strong technical momentum and unanimous analyst support, XLP offers defensive exposure with dividend income potential, but investors should monitor inflation pressures and consumer spending trends that could impact sector performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
